Plenary speakers

We are thrilled to announce our confirmed plenary speakers who will be in presenting at the ICCP450 Brisbane Conference.

Dr Fred Guengerich, Tadashi Inagami Professor of Biochemistry, Vanderbilt University School of Medicine

Dr Guengerich’s research deals with the chemical and biological mechanisms by which chemicals are processed and the relevance to drug development, toxicity and disease, focusing on human P450 enzymes and the molecular basis for substrate and reaction discriminiation. Dr Guengerich is a published author and serves as an associate editor of The Journal of Biological Chemistry. Dr Guengerich has trained 21 graduate students and 137 postdoctoral fellows and has received three Valderbilt mentoring awards as a result, as well as various other awards for his research in the P450 field.


Dr Birger Lindberg Møller, Professor of Plant Biochemistry, Plant Biochemistry Laboratory, University of Copenhagen

Dr Møllers lab has elucidated the catalytic roles of P450s in numerous biosynthetic pathways for plant natural products including cyanogenic glucosides and diterpenoids. Assembly of pathways in dynamic enzyme complexes (metabolons), identification of transcription factors controlling pathway expression, in planta compartmentalized storage of natural products in natural deep eutectic solvents and transfer of the pathways for compound production in heterologous hosts are current focus areas. Dr Møller´s research is supported by an ERC Advanced Grant and by the VILLUM, Novo Nordisk and Lundbeck Foundations.


Dr Irina Pikuleva, PhD, Carl F. Asseff Professor of Ophthalmology, Director of the Visual Sciences Research Center at Case Western Reserve University


Dr. Pikuleva received her PhD degree in Bioorganic Chemistry from the Byelorussian Academy of Sciences followed by postdoctoral training in Biochemistry at Vanderbilt University. In 1999, Dr. Pikuleva became a faculty member in the Department of Pharmacology and Toxicology at the University of Texas Medical Branch and then moved in 2008 to Case Western Reserve University. The two major areas of research in Dr. PIkuleva’s laboratory are studies of cholesterol metabolism in the brain and retina. The ultimate goal of these studies is to identify new therapeutic targets and treatments for diseases of the brain (Alzheimer’s disease) and the eye (age-related macular degeneration and diabetic retinopathy).


Dr Emily Scott, Professor of Medicinal Chemistry, Professor of Pharmacology, The University of Michigan

Dr Scott primarily focuses on research of the structure/function relationships of human cytochrome P450 enzymes. Her lab uses structural biology and biochemical techniques to understand drug metabolism and how to target specific P450 enxymes in disease pathways. Dr Scott’s work has been continuously funded by the National Institute of Health since 2004 and she has received multiple notable awards for her achievements in the P450 field.